Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamamatsu Introduces the New ImagEM X2

Published: Thursday, February 07, 2013
Last Updated: Thursday, February 07, 2013
Bookmark and Share
New EM CCD camera with fast 70 frames per second readout.

Hamamatsu Photonics has released the ImagEM X2, a new electron multiplying (EM) CCD camera with even faster speed than previous ImagEM cameras.

The ImagEM X2, a completely redesigned camera featuring a back-thinned EM-CCD sensor, offers maximum speed and precision performance for low-light imaging.

The ImagEM X2 makes superfast exposures possible and has the sensitivity to provide visually pleasing and quantitatively meaningful images in a photon-starved environment.

It delivers 70 frames/s at the full resolution of 512 x 512 pixels with a high signal-to-noise ratio, enabling quantitative high-speed, low-light imaging.

When binning or a region of interest is selected, this new camera produces images at even higher frame rates (up to 1076 frames/s).

Additional features allow for optimized camera triggering and streamlined connectivity through IEEE 1394b.

The ImagEM X2 also has improved overall signal-to-noise ratio, increased non-EM dynamic range, and built-in EM gain measurement and calibration functions.

It also features a software-controllable shutter that prevents EM gain degradation and image lag.

To prevent EM gain degradation, the shutter is closed when the built-in EM gain protection feature is enabled.

In addition, closing the shutter when a user replaces a lens, for example, can prevent image lag.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamamatsu Announces the Completion of a New Manufacturing Facility in Beijing
New building to expand both manufacturing capacity and R&D activities in China.
Saturday, March 29, 2014
Visiopharm and Hamamatsu Announce Worldwide OEM Agreement
Reseller partnership for quantitative digital pathology.
Monday, July 09, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!